GleamWall
中文EN

SMTI Sanara MedTech Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 714256 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.8%
TTM net income YoY92.0%
TTM EPS YoY91.9%
Revenue 3-yr CAGR21.4%
Net income 3-yr CAGR—

Margins

Gross margin93.0%
Operating margin5.6%
Net margin-2.7%
FCF margin6.5%
EBITDA margin7.8%

Returns

ROE-43.7%
ROA-4.2%
ROIC (approx.)13.3%
Asset turnover1.56x

Leverage & solvency

Liabilities / assets89.4%
Debt / equity6.10x
Current ratio2.24x
Interest coverage0.86x

Cash quality & payout

Operating cash flow / net income-2.46x
Accruals ratio-14.6%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$28.43M$28.14M$27.80M$27.55M$26.33M$25.80M$23.43M$26.31M
Cost of revenue$2.10M$1.98M$1.92M$1.87M$1.87M$1.94M$1.83M$2.25M
Gross profit$26.33M$26.16M$25.87M$25.67M$24.46M$23.87M$21.60M$24.06M
R&D expense$723,717$1.15M$759,592$2.04M$1.03M$1.06M$950,359$883,400
SG&A expense$24.25M$22.60M$21.88M$20.08M$19.88M$19.63M$19.13M$20.22M
Operating income$736,005$1.78M$2.65M$1.05M$2.94M$2.49M$825,530$2.26M
Interest expense$1.81M$1.81M$1.80M$1.83M$1.82M$1.79M$1.32M$1.29M
Net income-$1.41M-$452,864$458,957-$1.61M-$30.41M-$2.01M-$3.53M-$1.54M
EBITDA$1.35M$2.40M$3.23M$1.72M$3.55M$3.18M$1.95M$3.87M
EPS (basic)—-0.050.05—-3.52-0.23-0.41—
EPS (diluted)—-0.050.05—-3.40-0.23-0.41—
Weighted avg. shares (diluted)8.78M8.66M8.99M—8.94M8.93M8.57M—
Balance sheet
Cash & equivalents$16.79M$15.42M$13.59M$16.58M$14.94M$16.96M$20.69M$15.88M
Receivables$13.89M$12.57M$13.62M$12.00M————
Inventory$3.30M$3.46M$3.12M$3.95M$3.39M$3.51M$3.16M$2.75M
Current assets$36.40M$32.20M$31.20M$33.54M$31.23M$33.67M$36.84M$33.31M
PP&E, net$316,869$426,934$458,880$456,962$417,208$8.90M$2.06M$432,317
Goodwill$3.60M$3.60M$3.60M$3.60M$3.60M$3.60M$3.60M$3.60M
Intangibles$16.70M$17.28M$17.86M$18.64M$21.10M$40.99M$42.01M$23.48M
Total assets$72.24M$69.15M$69.28M$72.94M$71.09M$98.77M$96.38M$88.09M
Current liabilities$16.28M$12.49M$13.70M$18.63M$17.36M$14.88M$13.28M$15.29M
Long-term debt$46.72M$46.48M$46.23M$45.97M$45.09M$44.22M$43.40M$30.69M
Total debt$46.72M$46.48M$46.23M$45.97M$45.09M$44.22M$43.40M$30.69M
Total liabilities$64.57M$61.21M$62.26M$67.01M$64.95M$63.38M$59.71M$49.18M
Shareholders' equity$7.67M$7.94M$7.03M$5.94M$6.15M$35.40M$36.67M$39.40M
Net debt$29.94M$31.06M$32.63M$29.39M$30.15M$27.26M$22.71M$14.81M
Shares outstanding9.18M9.19M9.17M8.95M8.93M8.90M8.90M8.75M
Cash flow statement
Operating cash flow$3.90M$2.04M-$2.47M$3.95M$2.18M$2.66M-$2.00M$932,047
Capital expenditure$0$5,280$43,772$82,159$1.06M$1.76M$1.72M$72,172
Free cash flow$3.90M$2.03M-$2.51M$3.86M$1.12M$902,652-$3.72M$859,875
Investing cash flow-$1.76M-$5,280-$43,772-$2.45M-$3.42M-$3.93M-$5.18M-$129,994
Financing cash flow-$779,537-$206,481-$475,219$139,427-$774,749-$2.47M$11.99M-$1.20M
Depreciation & amortization$613,044$619,111$587,252$668,396$610,899$688,546$1.12M$1.61M
Stock-based compensation$1.27M$1.50M$1.03M$1.18M$41,948$130,174$1.30M$1.20M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.